Cargando…

Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons

CRISPR activation (CRISPRa) is an important tool to perturb transcription, but its effectiveness varies between target genes. We employ human pluripotent stem cells with thousands of randomly integrated barcoded reporters to assess epigenetic features that influence CRISPRa efficacy. Basal expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qianxin, Wu, Junjing, Karim, Kaiser, Chen, Xi, Wang, Tengyao, Iwama, Sho, Carobbio, Stefania, Keen, Peter, Vidal-Puig, Antonio, Kotter, Mark R., Bassett, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114495/
https://www.ncbi.nlm.nih.gov/pubmed/36917981
http://dx.doi.org/10.1016/j.molcel.2023.02.011
_version_ 1785028027282882560
author Wu, Qianxin
Wu, Junjing
Karim, Kaiser
Chen, Xi
Wang, Tengyao
Iwama, Sho
Carobbio, Stefania
Keen, Peter
Vidal-Puig, Antonio
Kotter, Mark R.
Bassett, Andrew
author_facet Wu, Qianxin
Wu, Junjing
Karim, Kaiser
Chen, Xi
Wang, Tengyao
Iwama, Sho
Carobbio, Stefania
Keen, Peter
Vidal-Puig, Antonio
Kotter, Mark R.
Bassett, Andrew
author_sort Wu, Qianxin
collection PubMed
description CRISPR activation (CRISPRa) is an important tool to perturb transcription, but its effectiveness varies between target genes. We employ human pluripotent stem cells with thousands of randomly integrated barcoded reporters to assess epigenetic features that influence CRISPRa efficacy. Basal expression levels are influenced by genomic context and dramatically change during differentiation to neurons. Gene activation by dCas9-VPR is successful in most genomic contexts, including developmentally repressed regions, and activation level is anti-correlated with basal gene expression, whereas dCas9-p300 is ineffective in stem cells. Certain chromatin states, such as bivalent chromatin, are particularly sensitive to dCas9-VPR, whereas constitutive heterochromatin is less responsive. We validate these rules at endogenous genes and show that activation of certain genes elicits a change in the stem cell transcriptome, sometimes showing features of differentiated cells. Our data provide rules to predict CRISPRa outcome and highlight its utility to screen for factors driving stem cell differentiation.
format Online
Article
Text
id pubmed-10114495
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-101144952023-04-20 Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons Wu, Qianxin Wu, Junjing Karim, Kaiser Chen, Xi Wang, Tengyao Iwama, Sho Carobbio, Stefania Keen, Peter Vidal-Puig, Antonio Kotter, Mark R. Bassett, Andrew Mol Cell Article CRISPR activation (CRISPRa) is an important tool to perturb transcription, but its effectiveness varies between target genes. We employ human pluripotent stem cells with thousands of randomly integrated barcoded reporters to assess epigenetic features that influence CRISPRa efficacy. Basal expression levels are influenced by genomic context and dramatically change during differentiation to neurons. Gene activation by dCas9-VPR is successful in most genomic contexts, including developmentally repressed regions, and activation level is anti-correlated with basal gene expression, whereas dCas9-p300 is ineffective in stem cells. Certain chromatin states, such as bivalent chromatin, are particularly sensitive to dCas9-VPR, whereas constitutive heterochromatin is less responsive. We validate these rules at endogenous genes and show that activation of certain genes elicits a change in the stem cell transcriptome, sometimes showing features of differentiated cells. Our data provide rules to predict CRISPRa outcome and highlight its utility to screen for factors driving stem cell differentiation. Cell Press 2023-04-06 /pmc/articles/PMC10114495/ /pubmed/36917981 http://dx.doi.org/10.1016/j.molcel.2023.02.011 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wu, Qianxin
Wu, Junjing
Karim, Kaiser
Chen, Xi
Wang, Tengyao
Iwama, Sho
Carobbio, Stefania
Keen, Peter
Vidal-Puig, Antonio
Kotter, Mark R.
Bassett, Andrew
Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title_full Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title_fullStr Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title_full_unstemmed Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title_short Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
title_sort massively parallel characterization of crispr activator efficacy in human induced pluripotent stem cells and neurons
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114495/
https://www.ncbi.nlm.nih.gov/pubmed/36917981
http://dx.doi.org/10.1016/j.molcel.2023.02.011
work_keys_str_mv AT wuqianxin massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT wujunjing massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT karimkaiser massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT chenxi massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT wangtengyao massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT iwamasho massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT carobbiostefania massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT keenpeter massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT vidalpuigantonio massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT kottermarkr massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons
AT bassettandrew massivelyparallelcharacterizationofcrispractivatorefficacyinhumaninducedpluripotentstemcellsandneurons